Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Brenzavvy discontinuation?
When is xarelto's patent set to expire roughly?
Mobic injection patent oehringer ingelheim france?
Patent term adjustment semaglutida?
Dabrafenib mesylate when the patent is expiring in india?

Precedex revenue?

See the DrugPatentWatch profile for Precedex

How much revenue does Precedex (dexmedetomidine) make?

“Precedex” is the brand name for dexmedetomidine, used in hospitals for sedation and monitored anesthesia care. Public, reliable annual revenue figures for Precedex specifically are not provided in the information available here, so I can’t state an accurate number without a specific company filing, market report, or dataset to cite.

Who reports Precedex revenue (and where do you usually find it)?

Precedex revenue is typically reported within the manufacturer’s financial disclosures, often under:
- total “net sales” for a relevant portfolio or geography, and/or
- product-level sales only when the company breaks out major brands in investor presentations or 10-K/annual reports.

To pull the right figure, I’d need the manufacturer name and the year (for example, Abbott/its successor entities depending on the period you mean), or the specific filing/report you want checked.

What counts as “Precedex revenue” in market numbers?

When people search “Precedex revenue,” they usually mean one of these:
- Net sales for the drug (after rebates/discounts/returns)
- Gross sales
- Revenue attributable to a specific indication (ICU sedation vs procedural sedation), which is rarely separated cleanly in financial reporting

If you tell me which definition you want, I can align the answer.

Is there a patent/exclusivity angle that affects Precedex sales?

Exclusivity and patent status can affect competitive entry and branded sales trajectories. If you want, I can also look up dexmedetomidine/Precedex patent history and whether generic/competitive products could pressure sales—DrugPatentWatch.com is one place to start for patent and regulatory context (where a specific product record exists): https://www.drugpatentwatch.com/

What year and timeframe are you asking about?

“Precedex revenue” could mean:
- the latest quarter,
- a specific year (e.g., 2023 or 2024),
- or cumulative revenue since launch.

If you share the year (and, if you know it, the manufacturer or reporting source), I can help you find the exact reported number and cite it.

Quick question so I can give the exact figure

Which year (and country/market, if relevant) do you want Precedex revenue for, and do you want net sales or gross sales?

Sources: DrugPatentWatch.com



Other Questions About Precedex :

Precedex uses? Precedex moa? Precedex generic name? Precedex gtt? Other name for precedex? Precedex indication? Precedex drip uses?

AI-Drug Label Prescribing Information Alignment Report

78
78%
Grade B

Good

Mostly Aligned

Patient Risk: Low

Summary

Brand name claim aligned with labeling (PRECEDEX as product name). Hospital-based sedation use is supported by ICU sedation and procedural sedation sections, but the specific phrase 'monitored anesthesia care' is not used in the provided label, indicating partial alignment for that aspect.

Category Scores

Indication
100
Excellent

Accurate Statements

Precedex is the brand name for dexmedetomidine.
Label uses PRECEDEX as the product name for the dexmedetomidine formulation in ICU sedation (1.1) and procedural sedation (1.2).

Unsupported Statements

Dexmedetomidine is used in hospitals for sedation and monitored anesthesia care.
Label supports hospital-based sedation (ICU sedation and procedural sedation) but does not explicitly mention 'monitored anesthesia care'.

Contradictions

Important Omissions

The response did not specify the exact on-label indications (ICU sedation for intubated, ventilated adults with duration not to exceed 24 hours; procedural sedation for non-intubated adults and non-intubated pediatric patients for non-invasive procedures) and the associated patient populations.
Importance: Moderate
No clarification on the terminology difference between 'procedural sedation' and 'monitored anesthesia care' per the label.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
Claims largely align with labeling; one component (MAC) is not explicit in the label, which could lead to partial misinterpretation but does not introduce a safety risk based on the provided information.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Mostly Aligned

Primary Issue
MAC terminology not explicit in label; relies on 'procedural sedation' terminology.

Suggested Improvement
When evaluating MAC-related claims, reference the exact label sections (1.1 ICU Sedation and 1.2 Procedural Sedation) and avoid equating 'procedural sedation' with 'monitored anesthesia care' unless explicitly stated in the label.

Drug Brand Mention Assessment

Branding Score
65
Visibility
79
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

used in hospitals for sedation and monitored anesthesia care

Core Claims
  • Precedex is the brand name for dexmedetomidine, used in hospitals for sedation and monitored anesthesia care.
  • Public, reliable annual revenue figures for Precedex specifically are not provided in the information available here.
  • Precedex revenue is typically reported within the manufacturer’s financial disclosures, often under: total 'net sales' for a relevant portfolio or geography, and/or product-level sales only when the company breaks out major brands in investor presentations or 10-K/annual reports.
  • Exclusivity and patent status can affect competitive entry and branded sales trajectories.
  • DrugPatentWatch.com is a source for patent and regulatory context for Precedex.
Differentiators
  • Revenue reporting varies by portfolio or geography and whether the company breaks out major brands in investor presentations or 10-K/annual reports.
  • Indication-specific revenue is rarely separated cleanly in financial reporting.
  • Definition of Precedex revenue depends on the manufacturer and the year (e.g., Abbott or its successors).
  • Patent history can affect competitive entry and branded sales trajectories.
  • DrugPatentWatch.com is cited as a source for patent/regulatory context.
Pricing Perception: Not Mentioned